Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Pharm Bull (Tokyo) ; 71(8): 650-654, 2023 Aug 01.
Article in English | MEDLINE | ID: mdl-37245988

ABSTRACT

Although aryl hydrocarbon receptors (AhRs) are related to the metabolic pathway of xenobiotics, recent studies have revealed that this receptor is also associated with the life cycle of viruses and inflammatory reactions. For example, flutamide, used to treat prostate cancer, inhibits hepatitis C virus proliferation by acting as an AhR antagonist, and methylated-pelargonidin, an AhR agonist, suppresses pro-inflammatory cytokine production. To discover a novel class of AhR ligands, we screened 1000 compounds derived from fungal metabolites using a reporter assay and identified methylsulochrin as a partial agonist of the aryl hydrocarbon receptor. Methylsulochrin was found to inhibit the production of hepatitis C virus (HCV) in Huh-7.5.1 cells. Methylsulochrin also suppressed the production of interleukin-6 in RAW264.7 cells. Furthermore, a preliminary structure-activity relationship study using sulochrin derivatives was performed. Our findings suggest the use of methylsulochrin derivatives as anti-HCV compounds with anti-inflammatory activity.


Subject(s)
Antiviral Agents , Receptors, Aryl Hydrocarbon , Male , Humans , Receptors, Aryl Hydrocarbon/agonists , Receptors, Aryl Hydrocarbon/metabolism , Antiviral Agents/pharmacology , Flutamide/pharmacology , Anti-Inflammatory Agents/pharmacology , Ligands
2.
Chem Pharm Bull (Tokyo) ; 70(10): 679-683, 2022.
Article in English | MEDLINE | ID: mdl-36184450

ABSTRACT

The liver X receptor is a nuclear hormone receptor that regulates lipid metabolism. Previously, we had demonstrated the antiviral properties of a liver X receptor antagonist associated with the hepatitis C virus and severe acute respiratory syndrome coronavirus 2. In this study, we screened a chemical library and identified two potential liver X receptor antagonists. Spectroscopic analysis revealed that the structures of both antagonists (compounds 1 and 2) were cyclic dimer and trimer of esters, respectively, that consisted of phthalate and 1,6-hexane diol. This study is the first to report the structure of the cyclic trimer of phthalate ester. Further experiments revealed that the compounds were impurities of solvents used for purification, although their source could not be traced. Both phthalate esters exhibited anti-hepatitis C virus activity, whereas the cyclic dimer showed anti-severe acute respiratory syndrome coronavirus 2 activity. Cyclic phthalate derivatives may constitute a novel class of liver X receptor antagonists and broad-spectrum antivirals.


Subject(s)
COVID-19 , Esters , Antiviral Agents/pharmacology , Esters/pharmacology , Hepacivirus , Hexanes , Humans , Liver X Receptors , Phthalic Acids , Receptors, Cytoplasmic and Nuclear , SARS-CoV-2 , Solvents
3.
Virology ; 562: 1-8, 2021 10.
Article in English | MEDLINE | ID: mdl-34242747

ABSTRACT

Bovine leukemia virus (BLV) infection has spread worldwide causing significant economic losses in the livestock industry. In countries with a high prevalence of BLV, minimizing economic losses is challenging; thus, research into various countermeasures is important for improving BLV control. Because anti-BLV drugs have not been developed, the present study explored a promising chemical compound with anti-BLV activity. Initially, screening of a chemical compound library revealed that violaceoid E (vioE), which is isolated from fungus, showed antiviral activity. Further analysis demonstrated that the antiviral effect of vioE inhibited transcriptional activation of BLV. Cellular thermal shift assay and pulldown assays provided evidence for a direct interaction between vioE and the viral transactivator protein, Tax. These data indicate that interference with Tax-dependent transcription could be a novel target for development of anti-BLV drugs. Therefore, it is suggested that vioE is a novel antiviral compound against BLV.


Subject(s)
Antiviral Agents/pharmacology , Leukemia Virus, Bovine/drug effects , Animals , Antiviral Agents/chemistry , Cats , Cattle , Cell Line, Transformed , Cell Survival/drug effects , Cell Transformation, Viral/drug effects , Gene Products, tax/antagonists & inhibitors , Humans , Transcriptional Activation/drug effects , Virus Replication/drug effects
4.
Bioorg Med Chem ; 27(23): 115149, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31679979

ABSTRACT

Pyrenocine A, a phytotoxin, was found to exhibit cytotoxicity against cancer cells with an IC50 value of 2.6-12.9 µM. Live cell imaging analysis revealed that pyrenocine A arrested HeLa cells at the M phase with characteristic ring-shaped chromosomes. Furthermore, as a result of immunofluorescence staining analysis, we found that pyrenocine A resulted in the formation of monopolar spindles in HeLa cells. Monopolar spindles are known to be induced by inhibitors of the kinesin motor protein Eg5 such as monastrol and STLC. Monastrol and STLC induce monopolar spindle formation and M phase arrest via inhibition of the ATPase activity of Eg5. Interestingly, our data revealed that pyrenocine A had no effect on the ATPase activity of Eg5 in vitro, which suggested the compound induces a monopolar spindle by an unknown mechanism. Structure-activity relationship analysis indicates that the enone structure of pyrenocine A is likely to be important for its cytotoxicity. An alkyne-tagged analog of pyrenocine A was synthesized and suppressed proliferation of HeLa cells with an IC50 value of 2.3 µM. We concluded that pyrenocine A induced monopolar spindle formation by a novel mechanism other than direct inhibition of Eg5 motor activity, and the activity of pyrenocine A may suggest a new anticancer mechanism.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Spindle Apparatus/drug effects , Cell Cycle Checkpoints/drug effects , HeLa Cells , Humans , Neoplasms/drug therapy , Pyrimidines/pharmacology , Pyrones/pharmacology , Thiones/pharmacology
5.
J Antibiot (Tokyo) ; 72(11): 793-799, 2019 11.
Article in English | MEDLINE | ID: mdl-31341274

ABSTRACT

New hydroquinone derivatives bearing a vinyl alkyne, pestalotioquinols A and B, were isolated from a fungal culture broth of Pestalotiopsis microspora. The structures of these novel compounds were determined by interpretation of spectroscopic data (1D/2D NMR, MS, and IR), and the absolute configuration of the stereogenic center of pestalotioquinol A was assigned using the modified Mosher's method. Nerve growth factor-differentiated neuronal PC12 cells were pretreated with pestalotioquinols A and B and removed from the medium, and then treated with a generator of peroxynitrite (ONOO-), a reactive nitrogen species, to induce cell death. The cytotoxicity of the treated cells was assessed by measuring lactate dehydrogenase leakage. As a result, 1-3 µM pretreatment of pestalotioquinols A and B rescued neuronal PC12 cells from peroxynitrite-induced cytotoxicity and the protective activity was sustained after removing each compound from the medium. These results demonstrate that pestalotioquinol derivatives are a new class of hydroquinones possessing a vinyl alkyne and exhibiting relatively high neuroprotective effects.


Subject(s)
Ascomycota/metabolism , Hydroquinones/chemistry , Hydroquinones/pharmacology , Animals , Cell Survival/drug effects , Molecular Structure , Neurons/drug effects , PC12 Cells , Rats
6.
Biosci Biotechnol Biochem ; 82(3): 442-448, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29447077

ABSTRACT

Neoechinulin A is an indole alkaloid with several biological activities. We previously reported that this compound protects neuronal PC12 cells from cytotoxicity induced by the peroxynitrite generator 3-morpholinosydnonimine (SIN-1), but the target proteins and precise mechanism of action of neoechinulin A were unclear. Here, we employed a phage display screen to identify proteins that bind directly with neoechinulin A. Our findings identified two proteins, chromogranin B and glutaredoxin 3, as candidate target binding partners for the alkaloid. QCM analyses revealed that neoechinulin A displays high affinity for both chromogranin B and glutaredoxin 3. RNA interference-mediated depletion of chromogranin B decreased the sensitivity of PC12 cells against SIN-1. Our results suggested chromogranin B is a plausible target of neoechinulin A.


Subject(s)
Chromogranin B/metabolism , Glutaredoxins/metabolism , Indole Alkaloids/metabolism , Neuroprotective Agents/metabolism , Peptide Library , Piperazines/metabolism , Animals , Chromogranin B/deficiency , Chromogranin B/genetics , Gene Silencing , Glutaredoxins/deficiency , Glutaredoxins/genetics , Indole Alkaloids/pharmacology , Neuroprotective Agents/pharmacology , PC12 Cells , Piperazines/pharmacology , Protein Binding , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...